← Back to Search

Saskatoon Berry for Metabolism Enhancement

N/A
Recruiting
Led By Garry Shen, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up onset and 10 weeks after the start of dietary intervention
Awards & highlights

Summary

This trial will examine the effect of Saskatoon berry on glucose metabolism, insulin resistance, and gut microbiota in healthy adults.

Who is the study for?
This trial is for healthy individuals living in Winnipeg who are willing to sign an informed consent. It's not open to those taking hypoglycemic, anti-hypertensive or lipid-lowering medications, antibiotics within the last month, or with a history of serious metabolic diseases.
What is being tested?
The study investigates the effects of freeze-dried Saskatoon berry on glucose metabolism, insulin resistance and gut microbiota in healthy adults. This pilot trial aims to explore if this berry can help manage or prevent type 2 diabetes and metabolic syndrome.
What are the potential side effects?
Since Saskatoon berries are natural foods, they may be safer than conventional hypoglycemic medications. However, potential side effects aren't detailed here; typically these could include digestive discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes from baseline to 10 weeks after the start of dietary intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes from baseline to 10 weeks after the start of dietary intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Glucose tolerance
Gut microbiome
Secondary study objectives
Blood pressure
Body mass index accord to body weight and height
C-reactive protein
+3 more
Other study objectives
Dietary intake, physical activities

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Single arm

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
612 Previous Clinical Trials
201,534 Total Patients Enrolled
Diabetes CanadaOTHER
10 Previous Clinical Trials
1,087 Total Patients Enrolled
Garry Shen, PhDPrincipal InvestigatorUniversity of Manitoba

Media Library

Saskatoon berry Clinical Trial Eligibility Overview. Trial Name: NCT04809688 — N/A
Nutritional and Metabolic Disorders Research Study Groups: Single arm
Nutritional and Metabolic Disorders Clinical Trial 2023: Saskatoon berry Highlights & Side Effects. Trial Name: NCT04809688 — N/A
Saskatoon berry 2023 Treatment Timeline for Medical Study. Trial Name: NCT04809688 — N/A
~8 spots leftby Oct 2025